Zobrazeno 1 - 10
of 13
pro vyhledávání: '"David Mametja"'
Autor:
Prof. Nicolas A Menzies, PhD, Gabriela B Gomez, PhD, Fiammetta Bozzani, MSc, Susmita Chatterjee, PhD, Nicola Foster, MPH, Ines Garcia Baena, MSc, Yoko V Laurence, MSc, Prof. Sun Qiang, PhD, Andrew Siroka, PhD, Sedona Sweeney, MSc, Stéphane Verguet, PhD, Nimalan Arinaminpathy, DPhil, Andrew S Azman, PhD, Eran Bendavid, MD, Stewart T Chang, PhD, Prof. Ted Cohen, DPH, Justin T Denholm, PhD, David W Dowdy, MD, Philip A Eckhoff, PhD, Jeremy D Goldhaber-Fiebert, PhD, Andreas Handel, PhD, Grace H Huynh, PhD, Marek Lalli, MSc, Hsien-Ho Lin, ScD, Sandip Mandal, PhD, Emma S McBryde, PhD, Surabhi Pandey, PhD, Prof. Joshua A Salomon, PhD, Sze-chuan Suen, MS, Tom Sumner, PhD, James M Trauer, MBBS, Bradley G Wagner, PhD, Prof. Christopher C Whalen, MD, Chieh-Yin Wu, MS, Delia Boccia, PhD, Vineet K Chadha, MD, Salome Charalambous, PhD, Daniel P Chin, MD, Prof. Gavin Churchyard, PhD, Colleen Daniels, MA, Puneet Dewan, MD, Lucica Ditiu, MD, Jeffrey W Eaton, PhD, Prof. Alison D Grant, PhD, Piotr Hippner, MSc, Mehran Hosseini, MD, David Mametja, MPH, Carel Pretorius, PhD, Yogan Pillay, PhD, Kiran Rade, MD, Suvanand Sahu, MD, Lixia Wang, MS, Rein M G J Houben, PhD, Michael E Kimerling, MD, Richard G White, PhD, Anna Vassall, PhD
Publikováno v:
The Lancet Global Health, Vol 4, Iss 11, Pp e816-e826 (2016)
Background: The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by 50% and mortality by 75% by 2025. We aimed to assess resource requirements and cost-effectiveness of strategies to achieve these targets in China, Ind
Externí odkaz:
https://doaj.org/article/3a2c5023c2c043b786c2c7197ab9fc55
Autor:
Dr. Rein M G J Houben, PhD, Nicolas A Menzies, PhD, Tom Sumner, PhD, Grace H Huynh, PhD, Nimalan Arinaminpathy, PhD, Jeremy D Goldhaber-Fiebert, PhD, Hsien-Ho Lin, PhD, Chieh-Yin Wu, MS, Sandip Mandal, PhD, Surabhi Pandey, PhD, Sze-chuan Suen, MS, Eran Bendavid, MD, Andrew S Azman, PhD, David W Dowdy, PhD, Nicolas Bacaër, PhD, Allison S Rhines, PhD, Prof. Marcus W Feldman, PhD, Andreas Handel, PhD, Prof. Christopher C Whalen, MD, Stewart T Chang, PhD, Bradley G Wagner, PhD, Philip A Eckhoff, PhD, James M Trauer, PhD, Justin T Denholm, PhD, Prof. Emma S McBryde, PhD, Ted Cohen, DPH, Prof. Joshua A Salomon, PhD, Carel Pretorius, PhD, Marek Lalli, MSc, Jeffrey W Eaton, PhD, Delia Boccia, PhD, Mehran Hosseini, MD, Gabriela B Gomez, PhD, Suvanand Sahu, MD, Colleen Daniels, MA, Lucica Ditiu, MD, Daniel P Chin, MD, Lixia Wang, MS, Vineet K Chadha, MD, Kiran Rade, MPhil, Puneet Dewan, MD, Piotr Hippner, MSc, Salome Charalambous, PhD, Prof. Alison D Grant, Prof. Gavin Churchyard, PhD, Yogan Pillay, PhD, L David Mametja, MPH, Michael E Kimerling, MD, Anna Vassall, PhD, Richard G White, PhD
Publikováno v:
The Lancet Global Health, Vol 4, Iss 11, Pp e806-e815 (2016)
Background: The post-2015 End TB Strategy proposes targets of 50% reduction in tuberculosis incidence and 75% reduction in mortality from tuberculosis by 2025. We aimed to assess whether these targets are feasible in three high-burden countries with
Externí odkaz:
https://doaj.org/article/f587d60093cc4ec18c3414ec3e0a14db
Autor:
Sizulu Moyo, Farzana Ismail, Martie Van der Walt, Nazir Ismail, Nkateko Mkhondo, Sicelo Dlamini, Thuli Mthiyane, Jeremiah Chikovore, Olanrewaju Oladimeji, David Mametja, Phaleng Maribe, Ishen Seocharan, Phumlani Ximiya, Irwin Law, Marina Tadolini, Khangelani Zuma, Samuel Manda, Charalambos Sismanidis, Yogan Pillay, Lindiwe Mvusi
Tuberculosis remains an important clinical and public health issue in South Africa, which has one of the highest tuberculosis burdens in the world. We aimed to estimate the burden of bacteriologically confirmed pulmonary tuberculosis among people age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe33eca8304c6114a1303a0a4e17312
https://hdl.handle.net/11585/907528
https://hdl.handle.net/11585/907528
Autor:
Kiran Rade, Piotr Hippner, Christopher C. Whalen, Philip A. Eckhoff, Delia Boccia, Nimalan Arinaminpathy, James M. Trauer, Daniel P. Chin, Ines Garcia Baena, Yoko V. Laurence, Jeffrey W. Eaton, Grace H. Huynh, Nicolas A Menzies, Emma S. McBryde, Susmita Chatterjee, Vineet K. Chadha, Suvanand Sahu, David W. Dowdy, Michael E. Kimerling, Colleen Daniels, Nicola L. Foster, Sun Qiang, Gavin J. Churchyard, Hsien-Ho Lin, Joshua A. Salomon, Richard G. White, Surabhi Pandey, Eran Bendavid, Bradley G. Wagner, Chieh Yin Wu, Mehran Hosseini, Sandip Mandal, Sze-chuan Suen, Alison D. Grant, Andrew M. Siroka, Puneet Dewan, Stéphane Verguet, Andreas Handel, Andrew S. Azman, Lixia Wang, Gabriela B. Gomez, Fiammetta Bozzani, Justin T Denholm, Lucica Ditiu, David Mametja, Anna Vassall, Marek Lalli, Jeremy D. Goldhaber-Fiebert, Tom Sumner, Yogan Pillay, Stewart T. Chang, Carel Pretorius, Sedona Sweeney, Rein M G J Houben, Salome Charalambous, Ted Cohen
Publikováno v:
e826
e816
The Lancet Global Health, Vol 4, Iss 11, Pp e816-e826 (2016)
lancet global health, 4(11), e816-e826. Elsevier BV
e816
The Lancet Global Health, Vol 4, Iss 11, Pp e816-e826 (2016)
lancet global health, 4(11), e816-e826. Elsevier BV
Summary Background The post-2015 End TB Strategy sets global targets of reducing tuberculosis incidence by 50% and mortality by 75% by 2025. We aimed to assess resource requirements and cost-effectiveness of strategies to achieve these targets in Chi
Autor:
Nimalan Arinaminpathy, Vineet K. Chadha, Tom Sumner, Marcus W. Feldman, Suvanand Sahu, Yogan Pillay, Carel Pretorius, Ted Cohen, Piotr Hippner, Emma S. McBryde, Philip A. Eckhoff, Lucica Ditiu, Jeffrey W. Eaton, Grace H. Huynh, Mehran Hosseini, Michael E. Kimerling, Joshua A. Salomon, Sze-chuan Suen, Andrew S. Azman, Gabriela B. Gomez, L. David Mametja, Sandip Mandal, Justin T Denholm, Allison S. Rhines, Marek Lalli, Gavin J. Churchyard, Rein M G J Houben, Richard G. White, Salome Charalambous, Jeremy D. Goldhaber-Fiebert, Hsien-Ho Lin, Stewart T. Chang, Lixia Wang, James M. Trauer, Daniel P. Chin, Nicolas Bacaër, Chieh Yin Wu, Anna Vassall, Alison D. Grant, David W. Dowdy, Kiran Rade, Colleen Daniels, Surabhi Pandey, Christopher C. Whalen, Eran Bendavid, Andreas Handel, Delia Boccia, Puneet Dewan, Nicolas A Menzies, Bradley G. Wagner
Publikováno v:
lancet global health, 4(11), e806-e815. Elsevier BV
The Lancet. Global Health
e815
e806
The Lancet Global Health, Vol 4, Iss 11, Pp e806-e815 (2016)
The Lancet. Global Health
e815
e806
The Lancet Global Health, Vol 4, Iss 11, Pp e806-e815 (2016)
Summary Background The post-2015 End TB Strategy proposes targets of 50% reduction in tuberculosis incidence and 75% reduction in mortality from tuberculosis by 2025. We aimed to assess whether these targets are feasible in three high-burden countrie
Autor:
N Bantubani, Lerole David Mametja, Claire C. Bristow, Laura Jean Podewils, L Bronner Murrison
Publikováno v:
SAMJ: South African Medical Journal, Volume: 106, Issue: 4, Pages: 394-398, Published: APR 2016
South African Medical Journal; Vol 106, No 4 (2016); 394-398
South African Medical Journal; Vol 106, No 4 (2016); 394-398
Background. The importance of using surveillance data to monitor and evaluate programme activities has been emphasised in international policies for tuberculosis (TB) control. Objectives. A survey was conducted to assess the use of TB surveillance da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a891be01feaaa1a132edde2acd019a9
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742016000400030&lng=en&tlng=en
http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742016000400030&lng=en&tlng=en
Autor:
Ananta Nanoo, David Mametja, Alane Izu, Shabir A. Madhi, Ibrahim Abubakar, Chikwe Ihekweazu, Nazir Ahmed Ismail
Publikováno v:
The Lancet. Infectious diseases. 15(9)
Summary Background South Africa has the highest incidence of tuberculosis in the world, largely resulting from a high population prevalence of HIV infection. We investigated the incidence of microbiologically confirmed pulmonary tuberculosis, and new
Autor:
Liza E Bronner, Julia Ershova, Laura Jean Podewils, Lerole David Mametja, Sicelo S Dlamini, Heather G. Stockwell
Publikováno v:
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 104(5)
Setting. Standardised tuberculosis (TB) treatment through directly observed therapy (DOT) is available in South Africa, but the level of adherence to standardised TB treatment and its impact on treatment outcomes is unknown. Objectives. To describe a
Autor:
Annatjie Peters, Laura Jean Podewils, Martie van der Walt, David Mametja, Claire C. Bristow, Liza E Bronner, Nonkqubela Bantubani
Publikováno v:
BMC Public Health
BackgroundIn 2008–2009 the South African National Tuberculosis (TB) Program (NTP) implemented a national pilot project, the TB Tracer Project, aiming to decrease default rates and improve patient outcomes. The current study aimed to inform the NTP
Autor:
Lerole David Mametja, Liza E Bronner, Laura Jean Podewils, Pushpakanthi Somnath, Martie van der Walt, Annatjie Peters, Lorna Nshuti
Publikováno v:
BMC Public Health, Vol 12, Iss 1, p 621 (2012)
BMC Public Health
BMC Public Health
Background Tuberculosis (TB) indicators in South Africa currently remain well below global targets. In 2008, the National Tuberculosis Program (NTP) implemented a community mobilization program in all nine provinces to trace TB patients that had miss